Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Novartis India to acquire Pfizer's Minipress trademark

PUBLIC · NVSSep 07, 2026about 9 hours ago

Acquiring Company

Novartis India Ltd

Acquired Company

Pfizer

SwitzerlandNew YorkBiotechnologyHealth CarepharmaceuticalsBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticals

Description

Novartis India Ltd has announced its acquisition of the 'Minipress' and 'Minipres' trademarks from Pfizer Inc. and Pfizer Products Inc. for about ₹1,250 crore. This transaction includes trademarks registered in India and certain intellectual property rights. An asset purchase agreement and trademark assignment deeds have been executed, with the signing and closing scheduled to occur simultaneously.

Company Information

Company

Novartis India Ltd

Location

2 Fabrikstrasse

Switzerland

About

Novartis India Ltd is a subsidiary of Novartis AG, focusing on healthcare products for chronic conditions. The company has a diverse portfolio including diabetes, neurology, and cardiology therapies. It operates in the Indian pharmaceutical market with a robust revenue stream. Novartis India aims to provide innovative solutions in healthcare.

Don't miss Novartis India Ltd's next move

Get an email the moment Novartis India Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Shreeram
Senior decision-maker at this company
••••••••@••••••••

See Shreeram's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Novartis India Ltd's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Pfizer?

Pfizer was acquired by Novartis India Ltd, based in Switzerland. The deal was reported on September 7, 2026. Novartis India Ltd is a subsidiary of Novartis AG, focusing on healthcare products for chronic conditions. The company has a diverse portfolio including diabetes, neurology, and cardiology therapies. Novartis India Ltd is publicly traded (NVS) and operates in Biotechnology.

When did Novartis India Ltd acquire Pfizer?

Novartis India Ltd's acquisition of Pfizer was reported on September 7, 2026. Novartis India Ltd has announced its acquisition of the 'Minipress' and 'Minipres' trademarks from Pfizer Inc. and Pfizer Products Inc. for about ₹1,250 crore. This transaction includes trademarks registered in India and certain intellectual property rights. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Pfizer do?

Seagen is a biotechnology company focused on developing innovative therapies for cancer treatment. The company specializes in antibody-drug conjugates and has a portfolio of targeted therapies. It is publicly traded (PFE), operating in Biotechnology, and is based in New York.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.